| FNARX | RYEAX | FNARX / RYEAX | |
| Total Expense Ratio | 0.69 | 1.62 | 43% |
| Annual Report Gross Expense Ratio | 0.69 | 1.67 | 41% |
| Fund Existence | 29 years | 28 years | - |
| Gain YTD | 16.718 | 25.797 | 65% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 867M | 44.9M | 1,931% |
| Annual Yield % from dividends | 1.93 | 2.34 | 83% |
| Returns for 1 year | 29.49 | 31.61 | 93% |
| Returns for 3 years | 61.17 | 38.32 | 160% |
| Returns for 5 years | 148.16 | 111.87 | 132% |
| Returns for 10 years | 144.36 | 62.59 | 231% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FFIMX | 23.59 | 0.12 | +0.52% |
| Fidelity Advisor Asset Manager 50% I | |||
| MGRFX | 17.24 | N/A | N/A |
| MassMutual Mid Cap Growth R5 | |||
| THPBX | 25.82 | N/A | N/A |
| BNY Mellon Balanced Opportunity J | |||
| TISVX | 19.41 | N/A | N/A |
| Transamerica International Sm Cp Val I | |||
| LYFCX | 18.66 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||